Victoria Brewster, MSW

Victoria Brewster, MSW

Social Justice Solutions | Staff Writer
Facebook web

Recap Of a Presentation On Personalized Medicine

By Victoria Brewster, MSW
Guest Blogger
The presentation was well worth the donation of $18 or chai.
Dr. Ido Amit, Department of Immunology, Weizmann Institute of Science in Israel and Dr. Sarit Assouline, Department of Oncology and Hematology, Jewish General Hospital (JGH) discussed Personalized Medicine. Dr. Amit stated that within 5-10 years this area will grow and new treatments will focus on care, medications and what to avoid.

The words used were Genomics and Genome which has to do with each persons genetics and genes. “Imagine a book with all the information of who you are”, a direct quote from Dr. Ido Amit. He also described the analogy of a radio, and taking a hammer to it, to describe diseases, chronic illnesses today and current treatments.

It appears that physicians do not always know what will work for a specific patient. Imagine someone with cancer (the radio) and taking a hammer (the treatment) to smash it to pieces hoping that will work for a patient. Now, imagine a radio where a specific part or piece can be targeted for treatment.

Dr. Sarit Assouline discussed cancer treatment at the JGH where she is employed. Personalized Medicine is used for a group of individuals who have been tested, and have had samples taken, to define their gene mutation. She used the example of one with Leukemia. A Bio-marker is identified, (the mutated gene) and a specific treatment (medication) is given to these individuals.

Gleevec is an example of a medication prescribed, and taken for life,  for newly diagnosed adult, and/or pediatric patient, with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase. Currently, this drug costs $3500 a month. Imagine spending that amount of money for the rest of your life and your insurance does not cover the whole cost of the medication.

Other issues raised were ethics, and regulatory bodies, in government or insurance. Who decides who pays and who approves a treatment? Like neuroplasticity which was not accepted by the medical field for many year.  The feeling was Personalized Medicine will also meet resistance.

First submitted to:


SJS Note – Recaps of conferences  workshops and the like are invaluable for the social work field and beyond. Sharing them is gift to your peers, and benefits those who present at the workshops, in short, please do so!

Our authors want to hear from you! Click to leave a comment

Related Posts

Subscribe to the SJS Weekly Newsletter

Leave a Reply